News | Ultrasound Women's Health | January 30, 2019

QTbreasthealth Opens New Breast Ultrasound Imaging Center in Grand Rapids

FDA-approved breast ultrasound system provides radiation-free 3-D imaging for secondary screening

QTbreasthealth Opens New Breast Ultrasound Imaging Center in Grand Rapids

January 30, 2019 — QTbreasthealth launched a center in Grand Rapids, Mich., featuring its quantitative transmission ultrasound technology known as the QTscan. The U.S. Food and Drug Administration (FDA)-cleared 3-D ultrasound breast imaging technology provides women an option with no radiation, no compression and no injections. It also provides unimpeded visibility for women with dense breast tissue. QTbreasthealth’s goal is to provide technology that encourages women to get scanned as often as necessary, with no risk.

The Grand Rapids center is the third QTbreasthealth location, following two California locations in Marin and Walnut Creek, with several more locations scheduled to open around the country throughout 2019. News of the Grand Rapids opening comes on the heels of ongoing clinical trials, which have found the QTscan to be successful in identifying various types of breast tissue, particularly within dense breasts.

The new Grand Rapids center, like all QTbreasthealth locations, offers a spa-like breast imaging experience, complete with soothing scents, comforting robes and a relaxing imaging scan that some women actually sleep through. Unlike most other breast imaging centers, QTbreasthealth patients receive results via phone or teleconference with a provider within 72 hours.

Because the QTscan uses no radiation, the exam is available to women of all ages and avoids the frequency limits associated with radiation-based imaging tests. The clear and comprehensive, 3-D image delivered by the QTscan also makes QTbreasthealth an ideal second opinion for breast imaging, providing a more detailed image than mammography or handheld ultrasound.

For more information: www.qtultrasound.com

Related Content

Christopher Comstock, M.D., ECOG-ACRIN Cancer Research Group study published in JAMA builds evidence for use of abbreviated MRI in women with dense breasts

Christopher Comstock, M.D., (Memorial Sloan Kettering Cancer Center) is the lead author of a paper in JAMA that reports that abbreviated breast MRI detected significantly more (almost 2 and a half times as many) breast cancers than digital breast tomosynthesis (3-D mammography) in average-risk women with dense breasts. Photo courtesy of Memorial Sloan Kettering Cancer Center

News | Breast Imaging | February 26, 2020
February 26, 2020 — According to a study
Women 75-plus May Not Benefit from Breast Cancer Screening
News | Mammography | February 25, 2020
February 25, 2020 — According to newly published research in an article titled...
Recognized as the “Pulitzer Prize of the business press,” the Jesse H. Neal Award finalists are selected for exhibiting journalistic enterprise, service to the industry and editorial craftsmanship
News | Radiology Business | February 19, 2020
February 19, 2020 — Connectiv, a division of The Software and Information Industry Association (SIIA), has announced
The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

News | Artificial Intelligence | February 13, 2020
February 13, 2020 — The U.S.
Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast

Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast. A small mass with micro-calcifications on the right-side breast was detected correctly by AI with an abnormality score of 96%. This case was recalled by 7 out of 14 radiologists (4 breast radiologists and 3 general radiologists) initially (without AI) and all 14 radiologists recalled this case correctly with the assistance of AI.

News | Artificial Intelligence | February 11, 2020
February 11, 2020 — A new study, published in...
Sponsored Content | Videos | Artificial Intelligence | February 06, 2020
ProFound AI is an FDA-cleared artificial intelligence (AI) system for reading 3-D breast tomosynthesis images.
Feature | Breast Imaging | February 03, 2020 | By Barbara Smith
Women in the United States have a 1 in 8 (or about 13 percent) lifetime risk of being diagnosed with breast cancer du
Automated Triage of Thyroid Cancer

73-year-old man with papillary carcinoma of left lobe of thyroid. Screen shot shows example of thyroid nodule annotation (segmentation and TI-RADS annotation) performed on ultrasound image in longitudinal projection with electronic Physician Annotation Device software (Stanford Medicine Radiology). Radiologists performed nodule segmentation by selecting points (red) on nodule outline (green), while controlling smoothing of outline polygon by means of spline interpolation.

News | Ultrasound Imaging | January 30, 2020
January 30, 2020 — According to an ar...